Naratuximab (Anti-TSPAN26 / CD37)

製品コード：A2600         Batch: A260002

印刷

Naratuximab (Anti-TSPAN26 / CD37) is a humanized monoclonal antibody targeting CD37 (TSPAN26). It can be used to synthesize an ADC compound, naratuximab emtansine which is used in treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). MW : 150 KD.

製品説明

CAS No. 1622327-39-2
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 6.37mg/ml
Endotoxin Level ＜1EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies [ Oncoimmunology, 2024, 13(1):2362454] PubMed: 38846084

人間や獣医の診断であるか治療的な使用のためにでない。